ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012

Six Institutions Get Awards For LAK-IL-2 Trials

February 7, 1986

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994